AVP, Clinical Services: Market Access Strategy

Precision AQ; New York (NY); Vor Ort; USD 180.000 - 220.000; Vollzeit

Benefits dieser Stelle

Health insurance

Retirement savings benefits

Life insurance

Disability benefits

Parental leave

Paid time off

Zusammenfassung

Precision AQ, a premier payer marketing agency, seeks an Associate Vice President, Clinical Services to steer clinical content development and guide strategic direction for select teams within market access. You will mentor staff, ensure standards, and contribute to business development and client strategy.

The role requires deep knowledge of pharmaceutical manufacturer strategies, managed markets, and communication of scientific evidence to payers, providers, patients, and policymakers.

Qualifikationen

• BA/BS in life sciences required.
• BA/BS in English with pharma agency experience acceptable.
• Minimum 9 years of experience in medical communication, pharmaceutical and/or healthcare industry.
• Managed markets promotional content development experience.
• Expertise in AMA style and scientific communication.

Aufgaben

• Lead and direct clinical content development across multiple accounts.
• Mentor Clinical Services team members and oversee initiatives.
• Resolve escalated issues between internal and external stakeholders.

Kenntnisse

AMA style

Written communication

Verbal communication

Interpersonal skills

Organizational awareness

Influencing others

Ausbildung

BA/BS in life sciences

BA/BS in English with pharma experience

Advanced degree (PharmD/PhD) preferred

Tools

Microsoft Word

PowerPoint

Adobe Acrobat

PubMed

Google Scholar

Jobbeschreibung

Precision AQ, a premier payer marketing agency, seeks an Associate Vice President, Clinical Services to steer clinical content development and guide strategic direction for select teams within market access. You will mentor staff, ensure standards, and contribute to business development and client strategy.

The role requires deep knowledge of pharmaceutical manufacturer strategies, managed markets, and communication of scientific evidence to payers, providers, patients, and policymakers.